# Nuclide record sr-89-chloride (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/sr-89-chloride/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "sr-89-chloride" ;
  schema:name "Strontium-89 chloride"@en ;
  schema:alternateName "Metastron"@en, "Strontium89"@en, "89SrCl2"@en, "Metastron" ;
  schema:description "A radioactive form of strontium is injected into a vein. Because it behaves like calcium, it collects in the damaged, overactive bone around cancer that has spread to bone, and its radiation can relieve bone pain for months."@en ;
  schema:url <https://nuclide.cc/drugs/sr-89-chloride/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020134s012lbl.pdf>, <https://tech.snmjournals.org/content/51/3/176> ;
  nuclide:status "approved" ;
  nuclide:tag "bone pain palliation", "beta emitter", "calcium mimetic" ;
  nuclide:modality "radioligand therapy" ;
  nuclide:approval "US 1993: Relief of bone pain in patients with painful skeletal metastases (presence of bone metastases must be confirmed prior to therapy)" ;
  nuclide:related <https://nuclide.cc/drugs/radium-223/>, <https://nuclide.cc/drugs/samarium-153-lexidronam/>, <https://nuclide.cc/terms/bone-metastases/>, <https://nuclide.cc/isotopes/ra-223/>, <https://nuclide.cc/isotopes/sm-153/>, <https://nuclide.cc/isotopes/sr-89/> .